Does ACLARUBICIN Cause Platelet count decreased? 21 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Platelet count decreased have been filed in association with ACLARUBICIN. This represents 6.7% of all adverse event reports for ACLARUBICIN.
21
Reports of Platelet count decreased with ACLARUBICIN
6.7%
of all ACLARUBICIN reports
5
Deaths
9
Hospitalizations
How Dangerous Is Platelet count decreased From ACLARUBICIN?
Of the 21 reports, 5 (23.8%) resulted in death, 9 (42.9%) required hospitalization, and 2 (9.5%) were considered life-threatening.
Is Platelet count decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ACLARUBICIN. However, 21 reports have been filed with the FAERS database.
What Other Side Effects Does ACLARUBICIN Cause?
Myelosuppression (80)
Bone marrow failure (73)
Off label use (38)
Nausea (35)
Infection (26)
Acute myeloid leukaemia (24)
Product use in unapproved indication (22)
Febrile neutropenia (19)
Pneumonia (19)
Thrombocytopenia (18)
What Other Drugs Cause Platelet count decreased?
LENALIDOMIDE (7,491)
NIRAPARIB (4,102)
ELTROMBOPAG OLAMINE (3,419)
RUXOLITINIB (3,028)
RITUXIMAB (2,404)
VENETOCLAX (2,367)
DEXAMETHASONE (2,321)
PALBOCICLIB (2,277)
CYCLOPHOSPHAMIDE (1,894)
RIBAVIRIN (1,701)
Which ACLARUBICIN Alternatives Have Lower Platelet count decreased Risk?
ACLARUBICIN vs ACLIDINIUM
ACLARUBICIN vs ACLIDINIUM\FORMOTEROL
ACLARUBICIN vs ACORAMIDIS
ACLARUBICIN vs ACTEMRA
ACLARUBICIN vs ACTIQ